Hims & Hers shares surged in May after the company said it would begin selling compounded versions of GLP-1 injections. What Happened: The FDA said in a statement late Wednesday that Eli Lilly's ...
On Friday, Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $17.77 which represents a slight increase of $0.06 or 0.34% from the prior close of $17.71. The stock opened at ...